Swiss National Bank held its stake in OraSure Technologies Inc. (NASDAQ:OSUR) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 106,600 shares of the company’s stock at the end of the second quarter. Swiss National Bank owned 0.19% of OraSure Technologies worth $630,000 as of its most recent SEC filing.
Several other large investors have also recently added to or reduced their stakes in the company. Springbok Capital Management LLC boosted its stake in OraSure Technologies by 126.7% in the first quarter. Springbok Capital Management LLC now owns 16,300 shares of the company’s stock worth $118,000 after buying an additional 9,110 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. bought a new stake in shares of OraSure Technologies during the first quarter worth approximately $127,000. Bayesian Capital Management LP bought a new stake in shares of OraSure Technologies during the first quarter worth approximately $137,000. Shikiar Asset Management Inc. boosted its stake in shares of OraSure Technologies by 28.6% in the second quarter. Shikiar Asset Management Inc. now owns 22,500 shares of the company’s stock worth $133,000 after buying an additional 5,000 shares during the period. Finally, Youngs Advisory Group Inc. boosted its stake in shares of OraSure Technologies by 37.8% in the second quarter. Youngs Advisory Group Inc. now owns 39,009 shares of the company’s stock worth $231,000 after buying an additional 10,706 shares during the period. Institutional investors and hedge funds own 79.65% of the company’s stock.
Shares of OraSure Technologies Inc. (NASDAQ:OSUR) traded up 0.77% on Thursday, hitting $7.86. The company’s stock had a trading volume of 149,516 shares. The company has a market cap of $437.02 million, a price-to-earnings ratio of 37.43 and a beta of 1.51. OraSure Technologies Inc. has a 52 week low of $4.52 and a 52 week high of $9.05. The stock’s 50 day moving average is $8.31 and its 200-day moving average is $7.30.
OraSure Technologies (NASDAQ:OSUR) last announced its earnings results on Wednesday, August 3rd. The company reported $0.07 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.05 by $0.02. OraSure Technologies had a return on equity of 7.60% and a net margin of 10.08%. The firm had revenue of $31.36 million for the quarter, compared to analysts’ expectations of $31.15 million. During the same quarter in the previous year, the company earned $0.03 earnings per share. The firm’s quarterly revenue was up 3.2% compared to the same quarter last year. On average, equities research analysts anticipate that OraSure Technologies Inc. will post $0.27 earnings per share for the current year.
A number of brokerages have commented on OSUR. BTIG Research reiterated a “buy” rating on shares of OraSure Technologies in a report on Wednesday, August 24th. Jefferies Group reiterated a “buy” rating and set a $10.00 target price (up previously from $8.00) on shares of OraSure Technologies in a report on Wednesday, August 31st. TheStreet upgraded OraSure Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, August 30th. Mizuho reiterated an “outperform” rating and set a $8.00 target price on shares of OraSure Technologies in a report on Tuesday, July 5th. Finally, Canaccord Genuity increased their target price on OraSure Technologies from $7.00 to $10.00 and gave the company a “buy” rating in a report on Wednesday, August 24th. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. OraSure Technologies presently has an average rating of “Buy” and a consensus target price of $8.58.
In other OraSure Technologies news, SVP Jack E. Jerrett sold 68,686 shares of OraSure Technologies stock in a transaction that occurred on Tuesday, August 30th. The shares were sold at an average price of $8.52, for a total value of $585,204.72. Following the transaction, the senior vice president now owns 86,441 shares in the company, valued at $736,477.32. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Charles W. Patrick sold 6,575 shares of OraSure Technologies stock in a transaction that occurred on Friday, August 5th. The stock was sold at an average price of $7.24, for a total transaction of $47,603.00. Following the completion of the transaction, the director now owns 77,209 shares in the company, valued at approximately $558,993.16. The disclosure for this sale can be found here. Corporate insiders own 7.80% of the company’s stock.
About OraSure Technologies
OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.